Status of immunotherapy: current and future.
Casale
Thomas B
TB
D000485:Allergens / Q000276:immunology; D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D052179:Antigens, Plant; D003888:Desensitization, Immunologic; D006801:Humans; D016753:Interleukin-10 / Q000096:biosynthesis; D009838:Oligodeoxyribonucleotides / Q000627:therapeutic use; D000069444:Omalizumab; D010940:Plant Proteins / Q000276:immunology
D000485:Allergens; C026967:Amb a I protein, Ambrosia artemisiifolia; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D052179:Antigens, Plant; C408982:CPG-oligonucleotide; D009838:Oligodeoxyribonucleotides; D010940:Plant Proteins; D016753:Interleukin-10; D000069444:Omalizumab